4.7 Article

Anonymity and secrecy options of recipient couples and donors, and ethnic origin influence in three types of oocyte donation

期刊

HUMAN REPRODUCTION
卷 26, 期 2, 页码 382-390

出版社

OXFORD UNIV PRESS
DOI: 10.1093/humrep/deq346

关键词

oocyte donation; psychology; anonymity; secrecy; cultural influence

向作者/读者索取更多资源

BACKGROUND: This study compares recipient couples' and donors' motivations towards the type of donation and attitudes concerning secrecy or disclosure of the mode of conception in three oocyte donation groups: couples and their donor for a known donation, couples and their donor for a permuted anonymous donation (known-anonymous) and couples without a donor, on a waiting list for a donation (anonymous). METHODS: Data collected by two psychologists through semi-structured interviews of 135 recipient couples and 90 donors before oocyte donation were analysed retrospectively. RESULTS: In known donation (42 couples), donors were preferentially family members with a blood tie (54.7%). Choosing their donor seemed mainly for the couple's reassurance rather than to access the child's origins as 50% wanted secrecy. On the other hand, in known-anonymous donation (48 couples), donors were more frequently chosen among friends (41.6%; P = 0.038). These couples were either open to disclosure (45.8%; P = 0.002) or remained hesitant (39.6%). In anonymous donation (45 couples), 49% chose not to seek a donor mostly in order to maintain secrecy towards the child (77.3%). Among the 51% who sought but could not find a donor, only 30.4% wanted secrecy. Recipients from North Africa and from Europe preferred anonymous or known-anonymous donation (83.3 and 75.6%), whereas sub-Saharan Africans opted more often for known donation (63%; P < 0.001). Among Europeans (90 couples), 50% were in favour of disclosure compared with only 8.9% of recipients from North or sub-Saharan Africa (45 couples; P < 0.001). CONCLUSIONS: A diversity of attitudes and cultural differences exist among recipient couples and donors regarding oocyte donation; this pleads for maintaining access to different types of oocyte donation as well as for psychological counselling prior to treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Obstetrics & Gynecology

Impact of ARTs on oncological outcomes in young breast cancer survivors

M. Condorelli, M. De Vos, S. Lie Fong, C. Autin, A. Delvigne, F. Vanden Meerschaut, C. Wyns, R. Imbert, C. Cheruy, J. Bouziotis, E. de Azambuja, A. Delbaere, M. Lambertini, I Demeestere

Summary: The risk of recurrence in young breast cancer survivors who undergo assisted reproductive technologies (ARTs) following completion of anticancer treatment does not appear to be increased, as shown by previous studies. More research is needed to confirm the safety of ART in this population.

HUMAN REPRODUCTION (2021)

Article Obstetrics & Gynecology

Ovarian tissue cryopreservation and transplantation in patients with central nervous system tumours

Thu Yen Thi Nguyen, Luciana Cacciottola, Alessandra Camboni, Joachim Ravau, Michel De Vos, Isabelle Demeestere, Jacques Donnez, Marie-Madeleine Dolmans

Summary: The study did not detect malignancy reseeding in cryopreserved ovarian tissue from 20 patients with CNS tumors, indicating a lack of tumor seeding in frozen-thawed and xenografted tissue.

HUMAN REPRODUCTION (2021)

Article Oncology

Cancer survivorship: Reproductive health outcomes should be included in standard toxicity assessments

Richard A. Anderson, Florian Clatot, Isabelle Demeestere, Matteo Lambertini, Adrienne Morgan, Scott M. Nelson, Fedro Peccatori, David Cameron

Summary: Cancer treatment can have adverse effects on reproductive function, leading to loss of fertility, sexual desire and function, and hormone deficiency. Proactive assessment and counseling on the impact of treatment on reproductive function are essential for patient mental health and quality of life. Providing accurate information and fertility preservation options can potentially influence treatment decisions and improve patient outcomes.

EUROPEAN JOURNAL OF CANCER (2021)

Article Oncology

Association of Germline BRCA Pathogenic Variants With Diminished Ovarian Reserve: A Meta-Analysis of Individual Patient-Level Data

Volkan Turan, Matteo Lambertini, Dong-Yun Lee, Erica Wang, Florian Clatot, Beth Y. Karlan, Isabelle Demeestere, Heejung Bang, Kutluk Oktay

Summary: The study found that young women with germline BRCA pathogenic variants, especially those affected and with BRCA1, have lower serum AMH levels compared to controls. This suggests they may need more counseling regarding the possibility of a shortened reproductive lifespan due to diminished ovarian reserve.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011)

Isabelle Demeestere, Judith Racape, Julie Dechene, Jehan Dupuis, Franck Morschhauser, Virginie De Wilde, Julien Lazarovici, Herve Ghesquieres, Mohamed Touati, David Sibon, Magda Alexis, Anne-Claire Gac, Hannah Moatti, Emmanuelle Virelizier, Herve Maisonneuve, Delphine Pranger, Roch Houot, Luc-Matthieu Fornecker, Adrian Tempescul, Marc Andre, Rene-Olivier Casasnovas

Summary: The PET-driven strategy significantly reduced the risk of gonadal dysfunction and infertility in patients with advanced Hodgkin lymphoma, particularly in terms of reducing premature ovarian insufficiency and low ovarian reserve. Men in the PET-driven group had better recovery of sperm parameters after treatment compared to the standard therapy group, with a lower risk of severe testicular damage and a higher likelihood of achieving pregnancy.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Oncology

Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis

Matteo Lambertini, Eva Blondeaux, Marco Bruzzone, Marta Perachino, Richard A. Anderson, Evandro de Azambuja, Philip D. Poorvu, Hee Jeong Kim, Cynthia Villarreal-Garza, Barbara Pistilli, Ines Vaz-Luis, Cristina Saura, Kathryn J. Ruddy, Maria Alice Franzoi, Chiara Sertoli, Marcello Ceppi, Hatem A. Azim, Frederic Amant, Isabelle Demeestere, Lucia Del Mastro, Ann H. Partridge, Olivia Pagani, Fedro A. Peccatori

Summary: This study found that breast cancer survivors are less likely to have a subsequent pregnancy compared to the general population, and they face higher risks during pregnancy, especially among those who have received chemotherapy. However, compared to breast cancer patients without subsequent pregnancy, those who become pregnant have better disease-free survival and overall survival rates.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Circulating Tumor DNA to Interrogate the Safety of Letrozole-Associated Controlled Ovarian Stimulation for Fertility Preservation in Breast Cancer Patients

Francoise Rothe, Matteo Lambertini, Oranite Goldrat, Marion Maetens, Yacine Bareche, Jeremy Blanc, Ghizlane Rouas, Denis Larsimont, Christos Sotiriou, Michail Ignatiadis, Isabelle Demeestere

Summary: The study assessed the safety of using let-COS in breast cancer patients for fertility preservation by analyzing ctDNA levels. Results showed that 93% of patients did not experience an increase in ctDNA levels after receiving let-COS, indicating its safety and efficacy for young women with early breast cancer interested in fertility preservation.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

A retrospective study evaluating the impact of scattering radiation from imaging procedures on oocyte quality during ovarian stimulation for fertility preservation in young breast cancer patients

Margherita Condorelli, Maelle Sens, Oranite Goldrat, Anne Delbaere, Judith Racape, Matteo Lambertini, Isabelle Demeestere

Summary: This study suggests that scattered ionizing radiation from staging assessment during ovarian stimulation for fertility preservation in breast cancer patients appears to be safe and does not compromise oocyte quality.

BREAST CANCER RESEARCH AND TREATMENT (2022)

Article Obstetrics & Gynecology

Risk of contamination of semen, vaginal secretions, follicular fluid and ovarian medulla with SARS-CoV-2 in patients undergoing ART

K. Kteily, D. Pening, P. Diaz Vidal, M. Devos, J. Dechene, A. Op de Beeck, A. Botteaux, S. Janssens, E. Van den Abbeel, O. Goldrat, A. Delbaere, I Demeestere

Summary: The study found that SARS-CoV-2 mRNA is not detectable in the reproductive tract of asymptomatic patients undergoing ART, regardless of the results from a triage questionnaire and a nasopharyngeal SARS-CoV-2 RNA detection test.

HUMAN REPRODUCTION (2022)

Article Oncology

Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer

M. Condorelli, M. Bruzzone, M. Ceppi, A. Ferrari, A. Grinshpun, A. S. Hamy, E. de Azambuja, E. Carrasco, F. A. Peccatori, A. Di Meglio, S. Paluch-Shimon, P. D. Poorvu, M. Venturelli, C. Rousset-Jablonski, C. Senechal, L. Livraghi, R. Ponzone, L. De Marchis, K. Pogoda, A. Sonnenblick, C. Villarreal-Garza, O. Cordoba, L. Teixeira, F. Clatot, K. Punie, R. Graffeo, M. Dieci, J. A. Perez-Fidalgo, F. P. Duhoux, F. Puglisi, A. R. Ferreira, E. Blondeaux, T. Peretz-Yablonski, O. Caron, C. Saule, L. Ameye, J. Balmana, A. H. Partridge, H. A. Azim, I Demeestere, M. Lambertini

Summary: In breast cancer survivors carrying germline BRCA1/2 pathogenic variants, assisted reproductive techniques (ART) may be a safe option when natural conception fails. Patients in the ART group were older and experienced more delivery complications, but there were no apparent differences in other obstetrical outcomes between the two groups.

ESMO OPEN (2021)

Letter Obstetrics & Gynecology

Reply: Risk of contamination with SARS-CoV-2 in ART

I Demeestere, E. van den Abbeel, A. Delbaere

HUMAN REPRODUCTION (2022)

Review Obstetrics & Gynecology

Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis

Hajra Khattak, Rosamund Malhas, Laurentiu Craciunas, Yousri Afifi, Christiani A. Amorim, Simon Fishel, Sherman Silber, Debra Gook, Isabelle Demeestere, Olga Bystrova, Alla Lisyanskaya, Georgy Manikhas, Laura Lotz, Ralf Dittrich, Lotte Berdiin Colmorn, Kirsten Tryde Macklon, Ina Marie Dueholm Hjorth, Stine Gry Kristensen, Ioannis Gallos, Arri Coomarasamy

Summary: Ovarian tissue cryopreservation and transplantation techniques have evolved over the past two decades with the aim of restoring fertility and hormonal function in women. Although evidence of success is largely based on case reports, studies demonstrate that this technology can restore reproductive and hormonal functions in women.

HUMAN REPRODUCTION UPDATE (2022)

Correction Obstetrics & Gynecology

Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis (Feb, 10.1093/humupd/dmac003, 2022)

Hajra Khattak, Rosamund Malhas, Laurentiu Craciunas, Yousri Afifi, Christiani A. Amorim, Simon Fishel, Sherman Silber, Debra Gook, Isabelle Demeestere, Olga Bystrova, Alla Lisyanskaya, Georgy Manikhas, Laura Lotz, Ralf Dittrich, Lotte Berdiin Colmorn, Kirsten Tryde Macklon, Ina Marie Dueholm Hjorth, Stine Gry Kristensen, Ioannis Gallos, Arri Coomarasamy

HUMAN REPRODUCTION UPDATE (2022)

Article Obstetrics & Gynecology

Impact of first chemotherapy exposure on follicle activation and survival in human cryopreserved ovarian tissue

Melody Devos, Paula Diaz Vidal, Jason Bouziotis, Ellen Anckaert, Marie-Madeleine Dolmans, Isabelle Demeestere

Summary: Chemotherapy exposure prior to ovarian tissue cryopreservation increases follicle apoptosis rates but not follicular activation. The PI3K/AKT/mTOR and Hippo signaling pathways are modified in the cortex. However, the consequences of treatment on follicle activation and survival require further investigation.

HUMAN REPRODUCTION (2023)

Article Oncology

Fertility Preservation in Childhood, Adolescent, and Young Adult Cancer 1 Fertility preservation for female patients with childhood , adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group

Renee L. Mulder, Anna Font-Gonzalez, Melissa M. Hudson, Hanneke M. van Santen, Erik A. H. Loeffen, Karen C. Burns, Gwendolyn P. Quinn, Eline van Dulmen-den Broeder, Julianne Byrne, Riccardo Haupt, W. Hamish Wallace, Marry M. van den Heuvel-Eibrink, Antoinette Anazodo, Richard A. Anderson, Anke Barnbrock, Joern D. Beck, Annelies M. E. Bos, Isabelle Demeestere, Christian Denzer, Natascia Di Iorgi, Holly R. Hoefgen, Rejin Kebudi, Cornelis Lambalk, Thorsten Langer, Lillian R. Meacham, Kenny Rodriguez-Wallberg, Catharyn Stern, Eveline Stutz-Grunder, Wendy van Dorp, Margreet Veening, Saskia Veldkamp, Eline van der Meulen, Louis S. Constine, Lisa B. Kenney, Marianne D. van de Wetering, Leontien C. M. Kremer, Jennifer Levine, Wim J. E. Tissing

Summary: This study aims to develop clinical practice guidelines for fertility preservation in female patients diagnosed with childhood, adolescent, and young adult cancer at age 25 years or younger. By utilizing the Grading of Recommendations Assessment, Development and Evaluation methodology, transparent recommendations were formed to facilitate the care of high-risk female patients. Collaboration led to a comprehensive review of existing evidence, transparent reporting, and achievement of global interdisciplinary consensus.

LANCET ONCOLOGY (2021)

暂无数据